Match!

CRISPR/Cas9-mediated Dax1 knockout in the monkey recapitulates human AHC-HH

Published on Dec 20, 2015in Human Molecular Genetics4.54
· DOI :10.1093/hmg/ddv425
Yu Kang8
Estimated H-index: 8
(Kunming University of Science and Technology),
Bo Zheng9
Estimated H-index: 9
(Nanjing Medical University)
+ 13 AuthorsXingxu Huang19
Estimated H-index: 19
(ShanghaiTech University)
Abstract
Mutations in the DAX1 locus cause X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HH), which manifest with primary adrenal insufficiency and incomplete or absent sexual maturation, respectively. The associated defects in spermatogenesis can range from spermatogenic arrest to Sertoli cell only syndrome. Conclusions from Dax1 knockout mouse models provide only limited insight into AHC/HH disease mechanisms, because mouse models exhibit more extensive abnormalities in testicular development, including disorganized and incompletely formed testis cords with decreased number of peritubular myoid cells and male-to-female sex reversal. We previously reported successful clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated genome targeting in cynomolgus monkeys. Here, we describe a male fetal monkey in which targeted genome editing using CRISPR/Cas9 produced Dax1-null mutations in most somatic tissues and in the gonads. This DAX1-deficient monkey displayed defects in adrenal gland development and abnormal testis architecture with small cords, expanded blood vessels and extensive fibrosis. Sertoli cell formation was not affected. This phenotype strongly resembles findings in human patients with AHC-HH caused by mutations in DAX1. We further detected upregulation of Wnt/β-catenin-VEGF signaling in the fetal Dax1-deficient testis, suggesting abnormal activation of signaling pathways in the absence of DAX1 as one mechanism of AHC-HH. Our study reveals novel insight into the role of DAX1 in HH and provides proof-of-principle for the generation of monkey models of human disease via CRISPR/Cas9-mediated gene targeting.
  • References (35)
  • Citations (40)
References35
Newest
#1Andrzej Slominski (UT: University of Tennessee)H-Index: 77
#2Wei Li (UT: University of Tennessee)H-Index: 38
Last.Robert C. Tuckey (UWA: University of Western Australia)H-Index: 39
view all 7 authors...
92 CitationsSource
#1Yongchang Chen (Kunming University of Science and Technology)H-Index: 13
#2Yiqiang Cui (Nanjing Medical University)H-Index: 11
Last.Xingxu Huang (National Resource Center)H-Index: 19
view all 12 authors...
19 CitationsSource
#1Yuanwu Ma (Academy of Medical Sciences, United Kingdom)H-Index: 7
#2Lianfeng Zhang (Academy of Medical Sciences, United Kingdom)H-Index: 7
Last.Xingxu Huang (National Resource Center)H-Index: 19
view all 3 authors...
47 CitationsSource
#1Yuyu NiuH-Index: 17
#2Bin Shen (National Resource Center)H-Index: 18
Last.Jiahao Sha (Nanjing Medical University)H-Index: 34
view all 28 authors...
628 CitationsSource
#1Bo Zheng (Nanjing Medical University)H-Index: 9
#2Quan Zhou (Nanjing Medical University)H-Index: 5
Last.Xiaoyan Huang (Nanjing Medical University)H-Index: 11
view all 10 authors...
15 CitationsSource
#1Prashant MaliH-Index: 31
#2Kevin M. EsveltH-Index: 18
Last.George M Church G MH-Index: 142
view all 3 authors...
787 CitationsSource
#1Marco Reis (Goethe University Frankfurt)H-Index: 3
#2Stefan Liebner (Goethe University Frankfurt)H-Index: 32
101 CitationsSource
35 CitationsSource
#1Donata Ponikwicka-Tyszko (PAN: Polish Academy of Sciences)H-Index: 6
#2Malgorzata Kotula-Balak (Jagiellonian University)H-Index: 17
Last.Slawomir Wolczynski (PAN: Polish Academy of Sciences)H-Index: 26
view all 5 authors...
9 CitationsSource
#1Lukas E. Dow (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 25
#2Scott W. Lowe (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 117
58 CitationsSource
Cited By40
Newest
#1Chu Chu (Kunming University of Science and Technology)H-Index: 1
#2Zhaohui Yang (Kunming University of Science and Technology)H-Index: 17
Last.Yuyu Niu (Kunming University of Science and Technology)H-Index: 17
view all 10 authors...
Source
#1Dan Zhao (Jiangsu University)H-Index: 1
#2Cong Shen (Nanjing Medical University)H-Index: 2
Last.Bo Zheng (Nanjing Medical University)H-Index: 9
view all 20 authors...
Source
#1Yu Kang (Kunming University of Science and Technology)
#2Chu Chu (Kunming University of Science and Technology)
Last.Yuyu Niu (Kunming University of Science and Technology)H-Index: 17
view all 4 authors...
Source
#1Jun Yu (Jiangsu University)H-Index: 1
#2Xiaojin Luan (Jiangsu University)H-Index: 1
Last.Jie Fang (Jiangsu University)H-Index: 1
view all 19 authors...
1 CitationsSource
#1Yasunari Seita (Shiga University of Medical Science)H-Index: 3
#2Tomoyuki Tsukiyama (Kyoto University)H-Index: 2
Last.Masatsugu Ema (Kyoto University)H-Index: 36
view all 13 authors...
2 CitationsSource
#1Jianguo Zhao (CAS: Chinese Academy of Sciences)
#2Liangxue Lai (Guangzhou Institutes of Biomedicine and Health)
Last.Qi Zhou (CAS: Chinese Academy of Sciences)H-Index: 54
view all 4 authors...
Source
#1Lucie Chansel-Debordeaux (University of Bordeaux)H-Index: 2
#2Erwan Bezard (University of Bordeaux)H-Index: 69
Source
2 CitationsSource
#1Nicole S. Lee (UMass: University of Massachusetts Amherst)H-Index: 2
#2Annaliese K. Beery (UMass: University of Massachusetts Amherst)H-Index: 17
1 CitationsSource
#1Fani Memi (UCL: University College London)H-Index: 6
#2Aglaia Ntokou (Yale University)H-Index: 1
Last.Irinna Papangeli (Yale University)H-Index: 8
view all 3 authors...
1 CitationsSource